Drugs / ATF936
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00417261 | Nov 2006 → Apr 2008 | — | Novartis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATF936 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00417261 ↗ |
| Modality | Small molecule | — CHEMBL597800 ↗ |
| Route | Oral | “ATF936 and AXT914 administered orally in healthy subjects” NCT00417261 ↗ |